GPT and Acute hepatitis: In the acute hepatitis model, Tung and colleagues showed that the four compounds tested were able to reduce serum levels of alanine transaminase (ALT) and aspartate transferase (AST), key markers of liver injury, in addition to attenuating serum levels of TNF-α and IL-6 in mice injected with LPS/D-GalN [89].